Co-signaling receptors regulate T-cell plasticity and immune tolerance
Frontiers in Bioscience · 2019 · 24 (1) · 96-132
DOI: 10.2741/4710 ↗At a glance
Journal article in Frontiers in Bioscience, 2019. Written by Haitao Shen and 18 co-authors. Institution: Department of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, China. Cited 43 times so far (Crossref). The full text is freely available in PubMed Central. Funded by: NHLBI NIH HHS, NIAID NIH HHS, NIDDK NIH HHS.
Abstract (original language)
We took an experimental database mining analysis to determine the expression of 28 co-signaling receptors in 32 human tissues in physiological/pathological conditions. We made the following significant findings: 1) co-signaling receptors are differentially expressed in tissues; 2) heart, trachea, kidney, mammary gland and muscle express co-signaling receptors that mediate CD4+T cell functions such as priming, differentiation, effector, and memory; 3) urinary tumor, germ cell tumor, leukemia and chondrosarcoma express high levels of co-signaling receptors for T cell activation; 4) expression of inflammasome components are correlated with the expression of co-signaling receptors; 5) CD40, SLAM, CD80 are differentially expressed in leukocytes from patients with trauma, bacterial infections, polarized macrophages and in activated endothelial cells; 6) forward and reverse signaling of 50% co-inhibition receptors are upregulated in endothelial cells during inflammation; and 7) STAT1 deficiency in T cells upregulates MHC class II and co-stimulation receptors. Our results have provided novel insights into co-signaling receptors as physiological regulators and potentiate identification of new therapeutic targets for the treatment of sterile inflammatory disorders.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, China.
- Department of Endocrinology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, China, 176818815@qq.com.
- Centers for Metabolic Disease Research, Cardiovascular Research, & Thrombosis Research, Lewis Katz School of Medicine at Temple University,Philadelphia, PA, 19140, U.S.A.
- Centers for Metabolic Disease Research, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, 19140, U.S.A.
- Centers for Metabolic Disease Research, Cardiovascular Research, & Thrombosis Research, Lewis Katz School of Medicine at Temple University ,Philadelphia, PA, 19140, U.S.A.
- Centers for Metabolic Disease Research, and Cardiovascular Research, and Thrombosis Research, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, 19140, U.S.A.
Funding
- NHLBI NIH HHS
- NIAID NIH HHS
- NIDDK NIH HHS
Cite
APA
Shen, H., Wu, N., Nanayakkara, G., Fu, H., Yang, Q., Yang, W. Y., Li, A., Sun, Y., Drummer Iv, C., Johnson, C., Shao, Y., Wang, L., Xu, K., Hu, W., Chan, M., Tam, V., Choi, E. T., Wang, H., & Yang, X. (2019). Co-signaling receptors regulate T-cell plasticity and immune tolerance. Frontiers in Bioscience, 24(1), 96-132. https://doi.org/10.2741/4710
Vancouver
Shen H, Wu N, Nanayakkara G, Fu H, Yang Q, Yang WY, et al. Co-signaling receptors regulate T-cell plasticity and immune tolerance. Frontiers in Bioscience. 2019;24(1):96-132. doi:10.2741/4710
BibTeX
@article{Shen2019,
author = {Shen, Haitao and Wu, Na and Nanayakkara, Gayani and Fu, Hangfei and Yang, Qian and Yang, William Y and Li, Angus and Sun, Yu and Drummer Iv, Charles and Johnson, Candice and Shao, Ying and Wang, Luqiao and Xu, Keman and Hu, Wenhui and Chan, Marion and Tam, Vincent and Choi, Eric T and Wang, Hong and Yang, Xiaofeng},
title = {Co-signaling receptors regulate T-cell plasticity and immune tolerance},
journal = {Frontiers in Bioscience},
year = {2019},
volume = {24},
number = {1},
pages = {96--132},
doi = {10.2741/4710}
}
EUVIMED